Skip to main content
Clinical Trials/NCT00825981
NCT00825981
Completed
Not Applicable

Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery

Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 site in 1 country100 target enrollmentJanuary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Disease
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Enrollment
100
Locations
1
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

Patients undergoing elective coronary artery bypass graft surgery (CABG) are treated with platelet inhibitors to reduce myocardial infarction and mortality.However, this can increase perioperative bleeding. A retrospective analysis of the data in our institution has revealed a significant increase in transfusion requirements after elective CABG since 5 years. The aim of our study is to observe if this increase in transfusion requirements is due to platelet inhibitors or due to other coagulation abnormalities resulting from other anticoagulants.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
March 2010
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Eligibility Criteria

Inclusion Criteria

  • coronary artery bypass graft surgery with or without cardiopulmonary bypass

Exclusion Criteria

  • emergency; redo cardiac surgery; combined cardiac surgery; patients with renal insufficiency; patients with acquired coagulation abnormalities

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials